Loading...
Blueprint Medicines Corporation
BPMC•NASDAQ
Healthcare
Biotechnology
$129.46
$0.18(0.14%)
Blueprint Medicines Corporation (BPMC) Financial Performance & Income Statement Overview
Review Blueprint Medicines Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
104.04%
↑ 104.04%
Operating Income Growth
56.39%
↑ 56.39%
Net Income Growth
86.77%
↑ 86.77%
Operating Cash Flow Growth
55.91%
↑ 55.91%
Operating Margin
-31.01%
↓ 31.009%
Gross Margin
95.84%
↑ 95.84%
Net Profit Margin
-27.70%
↓ 27.70%
ROE
-48.89%
↓ 48.89%
ROIC
-18.44%
↓ 18.44%
Blueprint Medicines Corporation (BPMC) Income Statement & Financial Overview
Review Blueprint Medicines Corporation's (BPMC) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $146.37M | $128.18M | $138.16M | $96.12M |
| Cost of Revenue | $7.45M | $1.93M | $11.21M | $8.001M |
| Gross Profit | $138.92M | $126.25M | $126.95M | $88.12M |
| Gross Profit Ratio | $0.95 | $0.98 | $0.92 | $0.92 |
| R&D Expenses | $83.67M | $85.30M | $80.65M | $83.38M |
| SG&A Expenses | $96.45M | $89.93M | $89.34M | $83.56M |
| Operating Expenses | $180.12M | $175.23M | $169.99M | $166.94M |
| Total Costs & Expenses | $187.57M | $177.16M | $181.20M | $174.94M |
| Interest Income | $10.39M | $11.15M | $9.94M | $9.18M |
| Interest Expense | $18.17M | $18.77M | $16.80M | $15.07M |
| Depreciation & Amortization | $4.001M | $3.86M | $3.62M | $4.81M |
| EBITDA | -$27.11M | -$33.37M | -$29.48M | -$74.01M |
| EBITDA Ratio | -$0.19 | -$0.26 | -$0.21 | -$0.77 |
| Operating Income | -$41.20M | -$48.97M | -$43.05M | -$78.82M |
| Operating Income Ratio | -$0.28 | -$0.38 | -$0.31 | -$0.82 |
| Other Income/Expenses (Net) | -$8.08M | -$7.03M | -$6.85M | $168.14M |
| Income Before Tax | -$49.28M | -$56.003M | -$49.89M | $89.32M |
| Income Before Tax Ratio | -$0.34 | -$0.44 | -$0.36 | $0.93 |
| Income Tax Expense | $672000.00 | $273000.00 | $102000.00 | $180000.00 |
| Net Income | -$49.96M | -$56.28M | -$49.99M | $89.14M |
| Net Income Ratio | -$0.34 | -$0.44 | -$0.36 | $0.93 |
| EPS | -$0.79 | -$0.89 | -$0.80 | $1.45 |
| Diluted EPS | -$0.79 | -$0.89 | -$0.80 | $1.40 |
| Weighted Avg Shares Outstanding | $63.12M | $63.38M | $62.85M | $61.58M |
| Weighted Avg Shares Outstanding (Diluted) | $63.12M | $63.38M | $62.85M | $63.80M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan